29 July 2020
Visiongain has launched a new report Personal Mobility Devices Market Report 2020-2030: Forecasts by Product (Wheelchair, Scooters, Walking Aids, Others), by End-user (Hospitals & Clinics, Ambulatory Surgical Centers, Urgent Care Center, Home Care Setting, and Others), and by Region (North America, Europe, Asia Pacific, Latin America & MEA), Including Forecasts by Major Developed Countries and Developing Countries, Plus Profiles of Leading Companies.
Personal mobility devices are assistive devices that help in individual human transportation. Mobility aid are usually employed by people suffering from disability as well as for general purposes. These devices are increasingly being used by public work departments as they promote independence and help decrease the extent of disability for the individual. Wheelchairs is the largest contributor to the global personal mobility devices as they are the most commonly opted assistive devices among the disabled patients. These devices improve the quality of life, enhances mobility, and reduce the possibility of any other problems.
The increase in the elderly population worldwide, rise in prevalence of target bone disorders such as osteoporosis and rheumatoid arthritis, and technological advancement in mobility devices are the major driving factors that help in growth of personal mobility devices market. As per the data by WHO, the geriatric population is expected to increase to 16% of the global population by 2050 as compared to 7% of the global population that were above 65 years in 2000. As per CDC, there were 54.4 million adults suffering from arthritis in the US. As the elderly people are highly prone to suffer from some age-related disease, there is a higher demand for mobility device among this population. These factors are expected to increase the demand for personal mobility devices in the near future.
The initiative by government to increase the adoption of mobility devices among the geriatric populations, favourable reimbursement policies, and increase in the number of road mishaps and spinal cord injuries further drives the growth of global personal mobility devices market. However, the high cost of these devices along with the high maintenance costs are expected to hamper the market growth.
The Visiongain report analyst commented “technological advancement in mobility devices such as emergence of better power wheelchairs and personal transporters is increasing the demand for mobility devices to promote independence and reduce the extent of disability. In addition, the rise in geriatric population, increase in the road mishaps and spinal cord injuries are further driving the growth of the personal mobility devices market”.
The report covers a detailed competitive outlook that includes market share and company profiles of key players operating in the global market. Key players profiled in the report include Carex Health Brands, Inc., Kaye Products, Inc., Briggs Healthcare, Drive DeVilbiss Healthcare, GF Health Products, Inc., Invacare Corporation, Medline Industries, Inc., NOVA Medical, Performance Health, and Rollz International.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The Macular Degeneration (AMD) and Other Retinal Diseases Drugs market was valued at US$25.29 billion in 2021 and is projected to grow at a CAGR of 7.87% during the forecast period 2022-2032.
25 November 2022
Pharmaceutical Contract Manufacturing Organisations (CMOs) market is projected to grow at a CAGR of 6.9% by 2032.
25 November 2022
The Dermatology CROs market was valued at US$ 5,154.8 million in 2021 and is projected to grow at a CAGR of 8.7% during the forecast period 2022-2032.
23 November 2022
The Direct-to-Patient market was valued at US$38,651 million in 2021 and is projected to grow at a CAGR of 6.1% during the forecast period 2022-2032.